Collectively, our data derived from cell lines, syngeneic mouse models, and specimen of patients with NSCLC revealed the prominent significance of TSC1/TSC2 mutations in promoting PD-L1 expression, facilitating T cell infiltration and augmenting tumor immunogenicity. Here, TSC1 is linked to neoplasm.